Introduction
Alzheimer's disease (AD) is a neurodegenerative disease with cognitive and memory dysfunctions. The main pathological features of AD are the formations of senile plaques (SPs) and neurofibrillary tangles (NFTs), as well as loss of cholinergic neurons in the basal forebrain [1] . The pathogenesis of AD is complex and remains still elusive. Genetic determinants have been defined by research on familial AD, which resulted in identification of mutations in 3 genes, amyloid β-protein precursor (APP) gene, presenilin-1 (PS1) gene, and presenilin-2 (PS2) gene [2] . However, in sporadic AD, the most common type of the disease, no mutations have been found. Therefore, transgenic AD animal models cannot faithfully model all aspects of AD [3] [4] [5] . The aim of the present study was to find a non-transgenic animal model that is relevant to the pathogenesis of AD. are decreased significantly in number [6, 7] . In addition, D-gal can induce behavioral impairment in C57BL/6J mice. D-galtreated mice show a significantly longer escape latency in the Morris water maze test. In object recognition test, D-gal reduces the discriminatory ability of mice and also their locomotor activity [8] . Besides, D-gal can shorten the lifespan of fruit fly (Drosophila melanogaster) and housefly (Musca domestica), associated with an increase in oxidative stress [9] . D-gal treatment can accelerate mouse aging due to the formation of advanced glycation endproducts (AGEs).
It is known that D-galactose (D-
These changes may contribute to aging and induce early aging-related diseases [10, 11] . Aluminum (Al) is a neurotoxin. After intragastric administration of Al, xanthine oxidase (XO) and glutathione peroxidase (GPX) activities are enhanced and depressed, respectively, leading to accumulation of intermediate toxic compounds such as hydrogen peroxide and hydroxyl radicals, which may mediate Al toxicity [12] . Following intracerebroventricular Al injection, immunoreactivity of astrocytes and phagocytic microglia, estimated by detection of glial fibrillary acidic protein (GFAP) and ED1, respectively, showed a stronger inflammatory response in rat brain. Enhancement of inflammation and interference with cholinergic projections may underlie the Al-caused learning and memory deficits [13] . Al has a specific toxic potential for cytoskeletal structures of brain cells [14] . The neuronal-specific markers microtubule-associated protein type 2 (MAP2) and neurofilament light subunit (NF68KD)
are inhibited at lower Al concentrations (IC 50 180-630 mmol/L) than GFAP (IC 50 700-1 000 mmol/L), demonstrating that neurons have a particularly high sensitivity to Al in comparison to astrocytes [15] . Chronic exposure to Al reduces the basal activity of guanylate cyclase and impairs the glutamate-nitric oxide-cyclic guanosine monophosphate (cGMP) pathway in vivo and in vitro. Al reduces the cerebellar content of calmodulin and nitric oxide synthase by 34% and 15%, respectively. In Al-treated rats, the basal activity of soluble guanylate cyclase decreases by 66%, whereas the basal cGMP in cerebellar extracellular space decreases by 50% [16, 17] . 
The change of cholinergic system in mice brain
After the completion of 5-d trials, acetylcholine (ACh) content was quantitatively measured using ACh ELlSA kit (Uscn Life Science Inc., Wuhan, China). Choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities were analyzed with the commercial kits (Nanjing Jiancheng Institute of Biotechnology, Nanjing, China), according to the standard spectrophotometric procedures.
SP immunohistochemical staining and NFT histochemical staining
Mice were anesthetized by intraperitoneal injection of 3% pentobarbitone (0.01 mL/g), and then fixed by 4% paraformaldehyde solution (pH 7.4). Brain was removed and embedded in paraffin wax.
Serial coronal sections were cut in 7-μm thickness and underwent conventional hematoxylin eosin (HE) staining, Aβ immunohistochemistry and Bielschowsky's silver staining, respectively, as described previously [20] , using mouse anti-Aβ Fig. 1 , the combined administration of D-gal and Al for 8 and 10 weeks increased significantly the escape latency (P < 0.01), and this effect was maintained for at least 6 weeks (P < 0.01).
Results

Morris water maze test As illustrated in
Administration of Al alone for 8 weeks did not increase the escape latency, while treatment for 10 weeks showed a significant effect (P < 0.01), but this effect was not observed at the end of the 6-week-period of drug withdrawal. On the contrary, administration of D-gal alone for 8 and 10 weeks both increased the escape latency (P < 0.05 and P < 0.01, respectively), and this effect was still observed at the end of the 6-week-period of drug withdrawal (P < 0.01) (Fig. 1A) .
The joint administration of D-gal and Al for 10 weeks significantly decreased the probing time spent in the target quadrant (P < 0.01), an effect persisting for 6 weeks (P < 0.01). Administration of Al alone for 10 weeks decreased the probing time (P < 0.05), but this effect disappeared at the end of the 6-week-period of drug withdrawal. On the contrary, administration of D-gal alone for 10 weeks decreased the probing time (P < 0.05), and this effect could also be detected at the end of the 6-week-period of drug withdrawal (P < 0.05) (Fig. 1B) . shown in Fig. 2 , combined administration of D-gal and Al for 8 and 10 weeks significantly decreased ACh brain content (P < 0.05, P < 0.01, respectively), and this was also observed at the end of the 6-week-drug withdrawal (P < 0.01). In contrast, administration of Al alone had no effect. Administration of D-gal alone for 8 and 10 weeks both showed a trend of decrease in ACh content, but with no statistical significance. However, at the end of the 6-week-D-gal withdrawal (16 weeks in total), ACh content was significantly decreased (P < 0.05) ( Fig. 2A) .
ACh content and activities of ChAT and AChE As
Combined administration of D-gal and Al for 8 and 10
weeks both significantly decreased ChAT activity (P < 0.05, (Fig. 2B) .
Similar as ChAT, AChE activity was significantly decreased by combined treatment with D-gal and Al for 8 and 10 weeks (P < 0.01), which persisted for 6 weeks (P < 0.01), whereas administration of Al alone had no effect. D-gal treatment alone for 8 or 10 weeks did not decrease AChE activity, either, but at the end of the 6-week-period of drug withdrawal, AChE activity was detected to be slightly decreased (P < 0.05) (Fig. 2C ). and error rate in behavioral tests, and increased skin hydroxyproline content [11] . Furthermore, these mice show septal nuclei and amygdala, where Al is prone to form deposits [23, 24] . Al toxicity is more readily induced in adult and aged than in juvenile animals, and susceptibility to the behavioral toxicity of Al increases steadily with age [25] .
Aβ
Following Al lactate or tartrate subcutaneous injection for 30 d in rabbits, formations of intraneuronal NFTs are detected in brain stem, cerebral cortex and hippocampus [14] . It has also been reported that Al increases APP gene expression in the brain [26] . Administration of aluminum trichloride in rats for 3 months induces APLI neurons in all sectors of the dorsal hippocampal formation [27] . Although SPs were not found, this study indicated that Al can increase
Aβ generation in neurons. Finally, metal chelating agent with trivalence has been suggested to slow the progress of AD [28] . This set of data strongly indicates that Al plays a significant role in AD. learning and memory, and can be increased in hippocampus and cortex by animal training [29] . ACh is synthesized by ChAT, and degraded by AChE, both of which have reduced activity in AD brain, resulting in an overall decrease of ACh concentration that may contribute to the decline in learning and memory. However, reports on the change of AChE activity in AD animal models are not consistent, with some reporting decreased, and others reporting increased concentration. These discrepancies may be due to 
